Adia Med Inc ADIA
0.13 USD +0.01 (+10.17%)
Nov 10, 2026, 2:51 PM EST
0.119 Day range 0.154
0.023 52-week range 0.278
- YTD
- +66.67%
- 1 year
- +209.52%
- Market cap
- 12.27M
- YTD return
- +66.67%
- 1-year return
- +209.52%
- Volume
- 3.21K
- Avg volume
- 20.93K
- Open
- 0.13
- Previous close
- 0.118
- Day's range
- 0.119 – 0.154
- 52-week range
- 0.023 – 0.278
No chart data for this range yet.
News
Adia Med CEO Larry Powalisz Issues Open Letter on Leadership Journey, Research Mission, and Progress Since 2024 
Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment Continues 
Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash 
Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position 
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million 
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line 
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products 
Nasdaq Shareholder Requirements Just Verified By Adia Med 
From Full Sail to Full-Scale: Adia Med Inc. Assembles Intern Social Media Team 
Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting
Your note
Sign in to keep a note on ADIA — it syncs with the Stock Master app.